Jiri Cyrany

Jiri Cyrany

Auto-generated profile, based on publicly available information

Jiri Cyrany

2nd Department of Internal Medicine – Gastroenterology, Charles University, University Hospital, Hradec Kralove, Czech Republic

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2013 in Gastroenterology Research and Practice
Verified
Journal Article
Open access
PDF file
MKMarcela Kopáčová
Marcela Kopáčová
OUOndrej Urban
Ondrej Urban
JCJiří Cyrany
Jiří Cyrany
JLJan Laco
Jan Laco
JBJan Bures
Jan Bures
ITIlja Tacheci
Ilja Tacheci
Cronkhite-Canada syndrome is a rare disease characterised by diffuse polyposis of the gastrointestinal tract, diarrhoea, weight loss, abdominal pain, cutaneous hyperpigmentation, dystrophic changes of fingernails, and alopecia. The etiology is probably autoimmune and diagnosis is based on history, physical examination, endoscopic findings of gastrointestinal polyposis, and histology. The disease is very rare; about 450 cases have been described in the literature so far. We present a review of the literature with our own picture documentation of this rare condition.

20 January 2014 in Endoscopy
Verified
Journal Article
Open access
JCJiri Cyrany
Jiri Cyrany
JMJan Melek
Jan Melek
PDPetr Dedek
Petr Dedek
JTJan Toms
Jan Toms
SRStanislav Rejchrt
Stanislav Rejchrt
The ingestion of a button-type battery cell by a child is an indication for urgent extraction (within 2 hours) if it has impacted in the esophagus because of the risks of major or even fatal complications, such as perforation and bleeding. In contrast, the ingestion of a cylindrical-type battery that passes into the stomach is not an indication for acute extraction as long as it is not causing symptoms. A follow-up radiograph after a 4-day interval is considered to be sufficient [1] [2]. We were asked to extract a cylindrical battery from the stomach of a 12-month-old asymptomatic girl approximately 26 hours after she had been witnessed ingesting it ([Fig. 1]). The procedure was performed with the patient under general anesthesia, using a gastroscope (GIF Q180; Olympus Optical Co., Tokyo, Japan) with a polypectomy snare. During the endoscopy, two ulcers, approximately 10 – 15 mm in diameter, were found on the front and back walls of the stomach ([Fig. 2]), together with several small erosions on the greater curvature ([Video 1]). The battery was identified as a type A23. A proton pump inhibitor was prescribed and ampicillin/sulbactam was added for complicating nasopharyngitis; otherwise the child’s subsequent course was uneventful. The supposed mechanism of battery-induced injury consists of (in order of importance): generation of an external electrolytic current that hydrolyses tissue fluids and produces hydroxide at the negative pole; leakage of alkaline electrolyte; and physical pressure [3]. A type-A23 battery consists of eight button alkaline cells (based on a manganese dioxide chemical system) bound together to form a cylinder that is 10 mm in diameter and 28 mm long and gives off a voltage as high as 12 V, as opposed to 1.5 V in more common and similar sized microbatteries (type AAA; 10 × 44 mm) [4]. We propose that in terms of the indication and timing of an endoscopic extraction of a cylindrical battery ingested by a child, the particular type and voltage of the battery should be considered, with particular regard being paid to the higher voltage types, such as A23 or A27. Potentially dangerous gastrointestinal tract damage could therefore be prevented. Endoscopy_UCTN_Code_CCL_1AB_2AF

29 June 2021 in Journal of Clinical Images and Medical Case Reports
Verified
Journal Article
Open access
JCJiri Cyrany
Jiri Cyrany
PSPavel Sieber
Pavel Sieber
SRStanislav Rejchrt
Stanislav Rejchrt

14 April 2023 in Endoscopy
Verified
Journal Article
Closed access
JCJ. Cyrany
J. Cyrany
KBK. Benesova
K. Benesova
JJJ. Jarkovsky
J. Jarkovsky
SRStanislav Rejchrt
Stanislav Rejchrt
ITIlja Tacheci
Ilja Tacheci
Aims To analyse an impact of coronavirus pandemic on gastroscopy service in the Czech Republic (CZ), including subanalyses of segments of diagnostic and therapeutic procedures. Methods Analysis from the National Registry of Reimbursed Health Services was performed with focus on the COVID-19 pandemic period (2020-2021) in comparison to 10 years of historical data. Results 277,277 gastroscopies were performed in the CZ in 2019, which represents 26 gastroscopies per 1,000 inhabitants per year. This amount was stable during the last 10 years (25.6-26.6 cases per 1000 inhabitants per year). Overall volume of gastroscopy procedures dropped by 15% and 9% during pandemic years 2020 and 2021, respectively (in comparison to 2019). This drop was regionally variable with wide ratios of 9-22% (2020) and 5-10% (2021) in individual regions. Number of haemostatic procedures is stable at around 5,000 per year and did not fall during the pandemic. The number of resections performed by endoscopic polypectomy, mucosal resection (EMR) and submucosal dissection (ESD) has doubled from 3,290 in 2010 to 6,514 cases in 2021 with no significant decrease during the pandemic. The ascending curve of yearly performed gastrostomies flattened during 2016-2018 on 4,300 procedures (4 gastrostomies per 10,000 inhabitants per year). The pandemic led to a moderate decline by 7% and 6% during 2020 and 2021, respectively, compared to 2019. Conclusions Coronavirus pandemic led to a significant reduction of gastroscopy service in the CZ. This reduction varied significantly between regions. Impact of pandemic on gastroscopy services was heterogenous with relative sparing of the main interventional procedures (gastrostomies, haemostatic and resection procedures). Article published online: 14 April 2023 © 2023. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

2 March 2026 in Military Medical Science Letters
Verified
Journal Article
Open access
PDF file
TVTomas Veleta
Tomas Veleta
JVJiri Vlcek
Jiri Vlcek
JCJiri Cyrany
Jiri Cyrany
RMRadovan Maly
Radovan Maly
TSTomáš Soukup
Tomáš Soukup
Background: The patterns of oral anticoagulant (OAC) prescription have significantly changed in recent years, with direct oral anticoagulants (DOACs) gradually replacing warfarin. While this transition occurred earlier in some countries, limited data are available about its timeline in the Czech Republic. Objectives: This study aimed to analyse trends in OAC prescriptions in the Czech Republic from 2019 to 2024, focusing on the shift from warfarin to DOACs and the patterns of utilisation of individual DOACs. Methods: A retrospective analysis was conducted using national electronic prescription data from the State Institute for Drug Control (SÚKL). Annual drug consumption is presented as defined daily doses per thousand inhabitants per day (DDD/TID). Results: Total OAC utilisation increased from 18.83 to 26.70 DDD/TID between 2019 and 2024 (p < 0.01), with an average of 22.99 ± 3.05 DDD/TID. DOACs surpassed warfarin in total prescriptions in 2021. Rivaroxaban (6.84 ± 3.00 DDD/TID) and apixaban (5.24 ± 2.43 DDD/TID) exhibited the highest growth, while dabigatran utilisation (3.00 ± 0.66 DDD/TID) showed a halt in increase after 2022. Conclusion: DOACs have progressively replaced warfarin in the Czech Republic, but this transition occurred later than in other developed countries. This shift was likely influenced by local changes in prescribing restrictions. Further research is warranted to evaluate prescription patterns based on specific indications.